In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Roche Diagnostics Corp.

www.roche-diagnostics.us

Latest From Roche Diagnostics Corp.

Coronavirus Antigen Testing Gets Green Light In Germany

Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.

Diagnostics Germany

New RWE Framework Aims To Get IVDs To Market Faster, Surveil COVID-19 Tests

Three years after the US FDA released a guidance to use real-world evidence in premarket applications, the stakeholder group MDIC has unveiled a framework for how IVD RWE can be captured and used by sponsors for premarket applications.

Regulation Research & Development

COVID-19 Testing Boosts Roche Diagnostics Sales In H1

Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.

Sales & Earnings Coronavirus COVID-19

COVID-19: Pandemic Could Bring Advances In Diagnostics Development, Experts Say

The diagnostics industry could benefit from a greater focus on real-world evidence linked to the COVID-19 pandemic, according to experts from the US FDA and industry.

Policy Cost Effectiveness
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
UsernamePublicRestriction

Register